vs
AC Immune SA（ACIU）与Rigetti Computing, Inc.（RGTI）财务数据对比。点击上方公司名可切换其他公司
Rigetti Computing, Inc.的季度营收约是AC Immune SA的1.3倍（$1.9M vs $1.4M），Rigetti Computing, Inc.净利率更高（-974.7% vs -1622.4%，领先647.8%），AC Immune SA同比增速更快（90.1% vs -17.9%）
AC Immune SA是一家临床阶段生物制药企业，专注于开发阿尔茨海默病、帕金森病及罕见tau蛋白病等神经退行性疾病的创新疗法与诊断方案，与全球领先药企展开合作，致力于满足神经疾病领域未被满足的临床需求。
Rigetti Computing总部位于美国加利福尼亚州伯克利，是专业的超导量子集成电路研发商，产品主要应用于量子计算机领域。公司还推出了名为Forest的云平台，支持开发者编写各类量子算法。
ACIU vs RGTI — 直观对比
营收规模更大
RGTI
是对方的1.3倍
$1.4M
营收增速更快
ACIU
高出108.0%
-17.9%
净利率更高
RGTI
高出647.8%
-1622.4%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.4M | $1.9M |
| 净利润 | $-23.3M | $-18.2M |
| 毛利率 | — | 34.9% |
| 营业利润率 | -1484.5% | -1209.7% |
| 净利率 | -1622.4% | -974.7% |
| 营收同比 | 90.1% | -17.9% |
| 净利润同比 | 6.9% | 88.1% |
| 每股收益（稀释后） | — | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACIURGTI
| Q4 25 | — | $1.9M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | $1.4M | $1.8M | ||
| Q1 25 | — | $1.5M | ||
| Q4 24 | — | $2.3M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | $755.7K | $3.1M | ||
| Q1 24 | — | $3.1M |
净利润ACIURGTI
| Q4 25 | — | $-18.2M | ||
| Q3 25 | — | $-201.0M | ||
| Q2 25 | $-23.3M | $-39.7M | ||
| Q1 25 | — | $42.6M | ||
| Q4 24 | — | $-153.0M | ||
| Q3 24 | — | $-14.8M | ||
| Q2 24 | $-25.0M | $-12.4M | ||
| Q1 24 | — | $-20.8M |
毛利率ACIURGTI
| Q4 25 | — | 34.9% | ||
| Q3 25 | — | 20.7% | ||
| Q2 25 | — | 31.4% | ||
| Q1 25 | — | 30.0% | ||
| Q4 24 | — | 44.1% | ||
| Q3 24 | — | 50.6% | ||
| Q2 24 | — | 64.5% | ||
| Q1 24 | — | 49.1% |
营业利润率ACIURGTI
| Q4 25 | — | -1209.7% | ||
| Q3 25 | — | -1055.4% | ||
| Q2 25 | -1484.5% | -1103.9% | ||
| Q1 25 | — | -1469.6% | ||
| Q4 24 | — | -813.3% | ||
| Q3 24 | — | -729.4% | ||
| Q2 24 | -3051.1% | -521.2% | ||
| Q1 24 | — | -543.4% |
净利率ACIURGTI
| Q4 25 | — | -974.7% | ||
| Q3 25 | — | -10321.9% | ||
| Q2 25 | -1622.4% | -2201.8% | ||
| Q1 25 | — | 2895.3% | ||
| Q4 24 | — | -6726.5% | ||
| Q3 24 | — | -623.8% | ||
| Q2 24 | -3313.0% | -402.5% | ||
| Q1 24 | — | -680.6% |
每股收益（稀释后）ACIURGTI
| Q4 25 | — | $-0.08 | ||
| Q3 25 | — | $-0.62 | ||
| Q2 25 | — | $-0.13 | ||
| Q1 25 | — | $0.13 | ||
| Q4 24 | — | $-0.80 | ||
| Q3 24 | — | $-0.08 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | — | $-0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.3M | $44.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $82.2M | $546.2M |
| 总资产 | $209.2M | $666.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACIURGTI
| Q4 25 | — | $44.9M | ||
| Q3 25 | — | $26.1M | ||
| Q2 25 | $28.3M | $57.2M | ||
| Q1 25 | — | $37.2M | ||
| Q4 24 | — | $67.7M | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | $56.7M | $20.7M | ||
| Q1 24 | — | $35.1M |
股东权益ACIURGTI
| Q4 25 | — | $546.2M | ||
| Q3 25 | — | $371.8M | ||
| Q2 25 | $82.2M | $553.3M | ||
| Q1 25 | — | $207.1M | ||
| Q4 24 | — | $126.6M | ||
| Q3 24 | — | $122.8M | ||
| Q2 24 | $135.8M | $122.2M | ||
| Q1 24 | — | $115.6M |
总资产ACIURGTI
| Q4 25 | — | $666.6M | ||
| Q3 25 | — | $630.3M | ||
| Q2 25 | $209.2M | $636.7M | ||
| Q1 25 | — | $269.1M | ||
| Q4 24 | — | $284.8M | ||
| Q3 24 | — | $157.3M | ||
| Q2 24 | $261.3M | $162.4M | ||
| Q1 24 | — | $162.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-14.9M |
| 自由现金流经营现金流 - 资本支出 | — | $-19.5M |
| 自由现金流率自由现金流/营收 | — | -1042.5% |
| 资本支出强度资本支出/营收 | — | 244.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-77.2M |
8季度趋势，按日历期对齐
经营现金流ACIURGTI
| Q4 25 | — | $-14.9M | ||
| Q3 25 | — | $-13.8M | ||
| Q2 25 | — | $-16.2M | ||
| Q1 25 | — | $-13.7M | ||
| Q4 24 | — | $-8.5M | ||
| Q3 24 | — | $-15.4M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-13.1M |
自由现金流ACIURGTI
| Q4 25 | — | $-19.5M | ||
| Q3 25 | — | $-19.7M | ||
| Q2 25 | — | $-21.8M | ||
| Q1 25 | — | $-16.2M | ||
| Q4 24 | — | $-9.8M | ||
| Q3 24 | — | $-17.7M | ||
| Q2 24 | — | $-15.6M | ||
| Q1 24 | — | $-18.6M |
自由现金流率ACIURGTI
| Q4 25 | — | -1042.5% | ||
| Q3 25 | — | -1012.4% | ||
| Q2 25 | — | -1212.4% | ||
| Q1 25 | — | -1100.4% | ||
| Q4 24 | — | -432.1% | ||
| Q3 24 | — | -744.5% | ||
| Q2 24 | — | -504.3% | ||
| Q1 24 | — | -610.5% |
资本支出强度ACIURGTI
| Q4 25 | — | 244.8% | ||
| Q3 25 | — | 302.5% | ||
| Q2 25 | — | 314.7% | ||
| Q1 25 | — | 173.0% | ||
| Q4 24 | — | 56.4% | ||
| Q3 24 | — | 95.8% | ||
| Q2 24 | — | 66.3% | ||
| Q1 24 | — | 180.0% |
现金转化率ACIURGTI
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.32× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACIU
暂无分部数据
RGTI
| Collaborative Research And Other Professional Services | $1.7M | 93% |
| Other | $131.0K | 7% |
